Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

NCT06162507 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: CM310

Sponsor

Keymed Biosciences Co.Ltd